Symphony Ltd

Symphony announced that the Board of Directors of the Company at its meeting held on 1 August 2025, inter alia, have recommended the first interim dividend of Rs 1 per equity Share (i.e. 50%) , subject to the approval of the shareholders.Powered by Capital Market - Live

Net profit of Symphony declined 52.27% to Rs 42.00 crore in the quarter ended June 2025 as against Rs 88.00 crore during the previous quarter ended June 2024. Sales declined 36.13% to Rs 251.00 crore in the quarter ended June 2025 as against Rs 393.00 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales251.00393.00 -36 OPM %10.3622.14 - PBDT47.0096.00 -51 PBT45.0094.00 -52 NP42.0088.00 -52 Powered by Capital Market - Live

The Board of Symphony at its meeting held on 25 July 2025 has reviewed and confirmed that the previously announced divestment/monetization of stake in Climate Technologies, Australia (CT) shall also extend to include the divestment/monetization of stake in Symphony AU (SAPL), Australia. SAPL, a wholly owned subsidiary (100%) of Symphony, was incorporated as a Special Purpose Vehicle (SPV) in 2018 for the acquisition of CT. SAPL is the holding company of CT and holds 100% of CT's equity shares. Powered by Capital Market - Live

Symphony will hold a meeting of the Board of Directors of the Company on 1 August 2025.Powered by Capital Market - Live

Symphony has fixed 07 August 2025 as record date for determining entitlement of the shareholders for the payment of 1st Interim Dividend for FY 2025-26, if declared. Powered by Capital Market - Live

Symphony announced that the 38th Annual General Meeting(AGM) of the company will be held on 1 August 2025.Powered by Capital Market - Live

The key equity indices traded sideways in mid-morning trade, as Fed Chair Jerome Powell cautioned that persistent tariff hikes could slow growth and drive long-term inflation. Investor sentiment was also weighed down by rising Indo-Pak tensions. The Nifty traded below the 24,450 mark. Market volatility was heightened due to the weekly expiry of the Nifty F&O series today. Pharma shares witnessed selling pressure for the third consecutive trading session. At 11:30 IST, the barometer index, the S&P BSE Sensex, rose 74.78 points or 0.09% to 80,821.56. The Nifty 50 index lost 2.60 points or 0.01% to 24,411.80. The broader market outperformed the frontline indices. The S&P BSE Mid-Cap index rose 0.41% and the S&P BSE Small-Cap index jumped 1.33%. The market breadth was strong. On the BSE, 2,609 shares rose and 956 shares fell. A total of 158 shares were unchanged. Buzzing Index: The Nifty Pharma index slipped 0.53% to 21,349.20. The index fell 1.95% in three consecutive trading sessions. Cipla (down 1.54%), Torrent Pharmaceuticals (down 1.14%), Dr Reddys Laboratories (down 0.90%), Divis Laboratories (down 0.89%), Alkem Laboratories (down 0.87%), Laurus Labs (down 0.85%), Lupin (down 0.81%), Aurobindo Pharma (down 0.68%), Granules India (down 0.55%) and Sun Pharmaceutical Industries (down 0.53%) declined. On the other hand, Gland Pharma (up 1.78%), Mankind Pharma (up 1.17%) and J B Chemicals & Pharmaceuticals (up 1.04%) edged higher. Stocks in Spotlight: Symphony surged 9.15% after the company's consolidated net profit jumped 64.58% to Rs 79 crore on 46.99% increase in revenue from operations to Rs 488 crore in Q4 FY25 over Q4 FY24. Dabur India slipped 2.18% after the company's consolidated net profit tumbled 8.34% to Rs 312.73 crore in Q4 FY25, compared with Rs 341.22 crore in Q4 FY24. Revenue from operations was at Rs 2,830.14 crore in the fourth quarter of FY25, marginally up 0.55% year on year. Blue Star lost 1.08%. The company reported consolidated net profit stood at Rs 194 crore in Q4 FY25, recording growth of 21.47%, compared with Rs 159.71 crore posted in Q4 FY24. Revenue from operations increased by 20.77% to Rs 4,018.96 crore for the fourth quarter ended 31 March 2025, as against Rs 3,327.77 crore during the same period the previous year. Global Markets: The US Dow Jones index futures were currently up by 223 points, signaling a positive opening for US stocks today. Most Asian markets advanced on Thursday after the U.S. Federal Reserve held interest rates steady, maintaining its benchmark overnight rate in the range of 4.25% to 4.5%, where it has remained since December. The move was widely anticipated by market participants. In a post-meeting press conference, Federal Reserve Chair Jerome Powell cautioned that the existing tariff increases could weigh on economic growth and contribute to higher long-term inflation if they remain in place. Investors are closely monitoring developments ahead of the upcoming U.S.-China trade talks. U.S. Treasury Secretary Scott Bessent is scheduled to meet his Chinese counterpart in Switzerland later this week to discuss trade and economic issues. U.S. equities closed higher on Wednesday, supported by gains in semiconductor stocks. The S&P 500 rose 0.4% to 5,631.27, the NASDAQ Composite gained 0.3% to 17,738.16, and the Dow Jones Industrial Average advanced 0.7% to 41,113.97. Markets responded to reports suggesting the Trump administration may reverse restrictions imposed during the Biden administration on the export of advanced artificial intelligence chips. These restrictions were originally intended to maintain U.S. leadership in AI technology and limit China's access to such products. A rollback could benefit U.S.-based chipmakers by enabling broader overseas sales. Shares of Nvidia rose 3.1% on the news, though the stock declined slightly in after-hours trading. U.S.-listed shares of TSMC gained 1.3% and were unchanged after hours. Intel ended the session up 1.9%. Separately, President Donald Trump announced via social media that he will hold a press conference on Thursday to unveil a 'major trade deal' with representatives of a 'big and highly respected country.' Media reports suggest the country involved is the United Kingdom, which has been engaged in ongoing trade negotiations with the U.S. Powered by Capital Market - Live

Profit before tax (PBT) climbed 89.66% YoY to Rs 110 crore during the quarter ended 31st March 2025. In Q4 FY25, EBITDA stood at Rs 103 crore, registering the growth of 77% as compared with Rs 59 crore posted in same quarter last year. EBTDA margin improved 358 bps to 21.22% in Q4 FY25 as against 17.64% in Q4 FY24. On full year basis, the company's consolidated net profit jumped 43.92% to Rs 213 crore in FY25 as compared with Rs 148 crore in FY24. Revenue from operations increased 36.33% to Rs 1,576 crore in FY25 as against 1,156 crore in FY24. On outlook front, the company said that the Indian summer of 2025 began with a promising start, and since then, the momentum is mild due to erratic summer. The company continues to focus across semi-urban and rural markets, as well as in the Modern Trade channel. It strategic focuses remains on scaling these growth markets, accelerating digital expansion, and deepening partnerships with Modern Trade. The company is building on the initial success of adjacent product categories, such as tower fans and kitchen cooling fans, which are sold year-round, and innovative storage water heaters, which are counter-seasonal products. In a strategic move to sharpen the company management's focus, it plans to exit from CT Australia and IMPCO Mexico, allowing to concentrate on core, growing, and highly profitable products and markets. This decision will optimize capital allocation and return on capital employed (ROCE). The USA market remains a highly attractive prospect, and we aim to leverage our proven track record to achieve sustainable growth and profitability. Meanwhile, the company's board recommended a final dividend of Rs 8 per share having face value of Rs 2 each for FY25. Symphony, an Indian multi-national company with presence in over 60 countries is the world's leading air cooler company. The company delivers market-leading products that comprise of design innovation, energy efficiency, distinctive styling, and customer-centricity.Powered by Capital Market - Live

Symphony announced that the Board of Directors of the Company at its meeting held on 7 May 2025, inter alia, have recommended the final dividend of Rs 8 per equity Share (i.e. 400%) , subject to the approval of the shareholders.Powered by Capital Market - Live

Net profit of Symphony rose 64.58% to Rs 79.00 crore in the quarter ended March 2025 as against Rs 48.00 crore during the previous quarter ended March 2024. Sales rose 46.99% to Rs 488.00 crore in the quarter ended March 2025 as against Rs 332.00 crore during the previous quarter ended March 2024. For the full year,net profit rose 43.92% to Rs 213.00 crore in the year ended March 2025 as against Rs 148.00 crore during the previous year ended March 2024. Sales rose 36.33% to Rs 1576.00 crore in the year ended March 2025 as against Rs 1156.00 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales488.00332.00 47 1576.001156.00 36 OPM %21.9317.17 -19.7314.53 - PBDT115.0064.00 80 348.00209.00 67 PBT110.0058.00 90 326.00183.00 78 NP79.0048.00 65 213.00148.00 44 Powered by Capital Market - Live